Antimetabolites: all 7,479 studies that test it
Page 64 of 75. Open to participants first (1,134), then studies with results posted, then the rest; newest registration first within each.
- Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic MelanomaActive, not recruitingNCT00338377Phase 2
- Gemcitabine for Marginal Zone LymphomaTerminatedNCT00337259Phase 2
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic LeukemiaCompletedNCT00337246Phase 2
- Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By SurgeryCompletedNCT00336960Phase 2
- Preop Chemoradiation Resectable PancreasCompletedNCT00336648Phase 2
- Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia MajorCompletedNCT00336362Not applicable
- Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell LymphomaActive, not recruitingNCT00336063Phase 1
- Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By SurgeryCompletedNCT00335543Phase 2
- CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung CancerCompletedNCT00330746Phase 2
- Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung CancerCompletedNCT00330044Phase 1
- Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung CancerWithdrawnNCT00329472Phase 3
- Study of Satraplatin With Capecitabine to Treat Advanced Solid MalignanciesTerminatedNCT00329329Phase 1
- Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT00327743Phase 1/2
- Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic AdenocarcinomaCompletedNCT00327327Phase 1
- Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic MelanomaCompletedNCT00324623Phase 1
- Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days RegimenStatus unknownNCT00324610Phase 1/2
- AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaStatus unknownNCT00324597Phase 1
- Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric AdenocarcinomaCompletedNCT00323830Phase 3
- Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerTerminatedNCT00323791Phase 2
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerStatus unknownNCT00323583Phase 2
- FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
- Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung CancerTerminatedNCT00321308Phase 2
- Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV MelanomaCompletedNCT00317759Phase 1
- Gemcitabine and Capecitabine in Patients With Advanced Pancreatic CancerCompletedNCT00316420Phase 1
- Topotecan in Combination With Pemetrexed in Patients With Advanced MalignanciesCompletedNCT00315861Phase 1
- Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple MyelomaCompletedNCT00313625Phase 2
- Dendritic Cell Vaccination During Lymphoid ReconstructionCompletedNCT00313508Phase 1
- Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer TherapyCompletedNCT00312988Phase 3
- Sequential Versus Combination Chemotherapy in Advanced Colorectal CarcinomaCompletedNCT00312000Phase 3
- Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell CarcinomaTerminatedNCT00311467Phase 3
- Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHLCompletedNCT00311129Phase 2
- Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaWithdrawnNCT00310128Phase 2
- Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00310011Phase 2
- Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative PatientsCompletedNCT00309569Phase 3
- Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast CancerCompletedNCT00309556Phase 3
- Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes CCompletedNCT00309530Phase 3
- Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsCompletedNCT00309478Phase 3
- Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic CancerTerminatedNCT00307723Phase 1/2
- Treatment of Necrotizing Vasculitides for Patients Older Than 65 YearsCompletedNCT00307671Phase 4
- IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic VasculitisTerminatedNCT00307645Phase 3
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid TumorsCompletedNCT00307255Phase 1
- Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00305786Phase 2
- Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal CancerCompletedNCT00305734Phase 2
- Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First RemissionCompletedNCT00305708Phase 1/2
- Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By SurgeryCompletedNCT00304135Phase 2/3
- Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00304018Phase 1
- Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase GeneCompletedNCT00303927Phase 2
- Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00303758Phase 3
- Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00303745Phase 2
- PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CMLCompletedNCT00303290Phase 1
- Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerCompletedNCT00301951Phase 1
- Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryStatus unknownNCT00301925Phase 3
- Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00301912Phase 2
- Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas CancerCompletedNCT00300950Phase 2
- Methotrexate in the Treatment of Axial SpondyloarthritisWithdrawnNCT00298012Phase 4
- Preoperative Combined Radiochemotherapy for Patients With Rectal CarcinomaCompletedNCT00297141Phase 2
- Preoperative Chemoradiation With Capecitabine and CetuximabCompletedNCT00297128Phase 2
- Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal CancerCompletedNCT00296608Phase 3
- Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerTerminatedNCT00296062Phase 1
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerCompletedNCT00296023Not applicable
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseCompletedNCT00295971Phase 1
- Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00295841Phase 1
- Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by GemcitabineCompletedNCT00294385Phase 3
- The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00294359Phase 2/3
- Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaStatus unknownNCT00293475Phase 1/2
- Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative DisordersCompletedNCT00293410Phase 1
- 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00293345Phase 1
- Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early ArthritisStatus unknownNCT00291915Phase 4
- Phase I/II CT 2106 and 5-FU/FA in Colorectal CancerCompletedNCT00291785Phase 1/2
- Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck CancerCompletedNCT00291707Phase 1
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerCompletedNCT00290641Not applicable
- Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTerminatedNCT00290017Phase 3
- Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)CompletedNCT00289445Phase 1/2
- Uric Acid in Essential Hypertension in ChildrenCompletedNCT00288184Phase 2
- Allopurinol for Renal Transplant Associated Hypertension in ChildrenWithdrawnNCT00288171Phase 1/2
- Primary Prevention of Hypertension in Obese AdolescentsCompletedNCT00288158Phase 2
- Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00288002Phase 3
- High-Dose Methotrexate in Treating Young Patients With Residual EpendymomaStatus unknownNCT00287924Phase 2
- Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric CancerCompletedNCT00287768Phase 3
- Clinical Trial of Chemosensitivity TestCompletedNCT00287755Phase 2
- Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung CancerCompletedNCT00284778Phase 3
- Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal CancerCompletedNCT00284258Phase 2/3
- Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell LymphomaCompletedNCT00283985Phase 2
- Iscar for Second Line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00283478Not applicable
- A Clinical Trial of Decitabine in Patients With Myelodysplastic SyndromeTerminatedNCT00282399Phase 1
- Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic CancerTerminatedNCT00281996Phase 1
- Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's MacroglobulinemiaCompletedNCT00281983Phase 1/2
- Combination Chemotherapy in Treating Young Patients With Advanced Solid TumorsCompletedNCT00281944Phase 1
- Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic LeukemiaTerminatedNCT00281931Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerCompletedNCT00281788Phase 1
- Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated CardiomyopathyWithdrawnNCT00281255Phase 1/2
- Leflunomide in Rheumatoid ArthritisCompletedNCT00280644Phase 4
- Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal CancerCompletedNCT00280176Phase 1
- Oxaliplatin and 5-FU Based Preoperative ChemoradiationCompletedNCT00278694Phase 2
- Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00278460Phase 2
- Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed GliomasStatus unknownNCT00278278Phase 3
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic LeukemiaCompletedNCT00276848Phase 3
- Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain MetastasesStatus unknownNCT00276783Phase 2
- Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00276588Phase 2
- Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue SarcomaCompletedNCT00276055Phase 1